Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones.

S H Hussaini, S P Pereira, M J Veysey, C Kennedy, P Jenkins, G M Murphy, J A Wass and R H Dowling

Gastroenterology Unit, Guy's Hospital Campus, UMDS, London.

BACKGROUND--Octreotide treatment of acromegalic patients increases the % deoxycholic acid conjugates and the cholesterol saturation of gall bladder bile, and induces gall stone formation. AIMS--To study the roles of gall bladder emptying and intestinal transit in these phenomena. METHODS AND PATIENTS--Gall bladder emptying and mouth to caecum transit was measured in (a) control subjects and acromegalic patients given saline or 50 micrograms of octreotide, and (b) acromegalic patients taking long term octreotide. In the second group, large bowel transit was also measured. RESULTS--A single dose of octreotide inhibited meal stimulated gall bladder emptying, the ejection fraction falling from mean (SEM) 66.0 (2.3)% to 7.0 (5.3)% in controls (p < 0.001); from 72.5 (2.1) to 16.6 (5.1)% in untreated acromegalic patients (p < 0.001), and to 30.4 (9.5)% in acromegalic patients taking long term octreotide (p < 0.001 v untreated acromegalic group). Octreotide prolonged mouth to caecum transit time, from 112 (15) min to 237 (13) min in controls (p < 0.001), from 170 (13) min to 282 (11) min in untreated acromegalic patients (p < 0.001), and to 247 (10) min in acromegalic patients taking long term octreotide (p < 0.001 v untreated acromegalic patients). The mean large bowel transit in octreotide untreated compared with treated acromegalic patients remained unchanged (40 (6) h v 47 (6) h). CONCLUSIONS--Prolongation of intestinal transit and impaired gall bladder emptying may contribute to lithogenic changes in bile composition and gall stone formation in patients receiving long term octreotide.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Hofmann, A F (2005). Increased deoxycholic acid absorption and gall stones in acromegalic patients treated with octreotide: more evidence for a connection between slow transit constipation and gall stones. Gut 54: 575-578 [Full Text]  
• Thomas, L A, Veysey, M J, Murphy, G M, Russell-Jones, D, French, G L, Wass, J A H, Dowling, R H (2005). Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly. Gut 54: 630-635 [Abstract] [Full Text]  
• Veysey, M J, Malcolm, P, Mallet, A I, Jenkins, P J, Besser, G M, Murphy, G M, Dowling, R H (2001). Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial. Gut 49: 828-834 [Abstract] [Full Text]  
• Thomas, L. A., Veysey, M. J., Murphy, G. M., Dowling, R. H. (2001). Influence of pH on the phase distribution of nascent deoxycholic acid in fresh human cecal aspirates. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G371-G374 [Abstract] [Full Text]  
• Jenkins, P. J., Besser, M. (2001). CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem. J. Clin. Endocrinol. Metab. 86: 2935-2941 [Full Text]  
• Acalovschi, M (2001). Cholesterol gallstones: from epidemiology to prevention. Postgrad. Med. J. 77: 221-229 [Full Text]  
• JENKINS, P J, BESSER, G M, FAIRCLOUGH, P D (1999). Colorectal neoplasia in acromegaly. Gut 44: 585-587 [Full Text]  
• Veysey, M J, Thomas, L A, Mallet, A I, Jenkins, P J, Besser, G M, Wass, J A H, Murphy, G M, Dowling, R H (1999). Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones. Gut 44: 675-681 [Abstract] [Full Text]  
• Gielkens, H A J, van den Biggelaar, A, Vecht, J, Onkenhout, W, Lamers, C B H W, Masclee, A A M (1999). Effect of intravenous amino acids on interdigestive antroduodenal motility and small bowel transit time. Gut 44: 240-245 [Abstract] [Full Text]